Kiko “Kla” ta nifiká?
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
The Intestinal Cobalamin Malabsorption (IGS) DNA test in Australian Shepherd Variant 1 is essential for early detection of this inherited disorder. IGS affects vitamin B12 absorption, leading to serious health issues in affected dogs. By using this genetic test, breeders and owners can identify carriers and prevent passing the mutation to future generations. Early diagnosis through DNA testing ensures timely treatment and improved quality of life for Australian Shepherds. This test is a vital tool for responsible breeding and maintaining the breed’s overall health. Protect your Australian Shepherd by screening for IGS Variant 1 today. Accurate DNA testing supports healthier, happier dogs.
Imerslund-Gräsbeck Syndrome
The DNA test for Intestinal Cobalamin Malabsorption (IGS) Variant 1 in Australian Shepherds helps identify carriers and affected dogs. IGS is a genetic disorder causing poor absorption of vitamin B12, leading to serious health issues. Early detection through this test allows breeders to make informed decisions and reduce the risk of passing the condition to offspring. Affected dogs require lifelong management and supplementation. This test is essential for maintaining the health and well-being of Australian Shepherds.
E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.
Wak e paketenan di tèst di DNA →Intestinal Cobalamin Malabsorption (ICM) is a genetic condition observed in Australian Shepherds, specifically associated with the IGS (Intestinal Cobalamin Malabsorption) variant 1. This hereditary disorder leads to the inability of the intestines to properly absorb cobalamin, also known as vitamin B12, which is essential for various bodily functions, including red blood cell production and neurological health.
The IGS variant 1 is linked to mutations in specific genes that are crucial for the absorption of cobalamin. These genetic alterations affect the transport mechanisms within the intestines, resulting in insufficient levels of vitamin B12 in the bloodstream. Affected dogs often experience symptoms related to vitamin deficiency, which can significantly impact their overall health and well-being.
Dogs diagnosed with ICM may exhibit a variety of clinical symptoms. Common signs include poor growth, weight loss, lethargy, and gastrointestinal issues such as diarrhea or vomiting. As the condition progresses, it can lead to more severe health problems, including anemia and neurological disorders due to the critical role of cobalamin in maintaining cellular function and health.
To confirm a diagnosis of Intestinal Cobalamin Malabsorption, veterinarians often rely on a combination of clinical signs and diagnostic testing, including blood tests to measure cobalamin levels. However, DNA testing is a definitive method to identify the presence of the genetic mutation associated with the condition. This allows for early detection and management of the disease, enhancing the quality of life for affected dogs.
Management of Intestinal Cobalamin Malabsorption primarily involves cobalamin supplementation to restore adequate vitamin levels in the body. This can be achieved through regular injections or oral supplements, depending on the severity of the deficiency and the dog's individual needs. In addition to vitamin supplementation, a well-balanced diet and regular veterinary check-ups are crucial for monitoring overall health and addressing any additional complications that may arise from the condition.
Intestinal Cobalamin Malabsorption in Australian Shepherds is a significant genetic condition that can lead to serious health issues if not properly managed. Early diagnosis through DNA testing and subsequent treatment with cobalamin supplementation can help affected dogs lead healthier and more fulfilling lives. Responsible breeding practices and genetic testing can also play a vital role in reducing the incidence of this condition in future generations.
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
No. E animal ta generalmente salú pero por transmití e mutashon na su yu.
E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.
Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.
This DNA test detects the mutation associated with Intestinal Cobalamin Malabsorption In Australian Shepherd Variant 1 (IGS-AS1) in order to identify clear, carrier, or at-risk animals.
Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.
E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.
This test analyses the mutation CUBN c.8392del.
No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.
OwczarekLipska Marta, Jagannathan Vidhya, Drögemüller Cord, Lutz Sabina, Glanemann Barbara, Leeb Tosso, Kook Peter H. A frameshift mutation in the cubilin gene (CUBN) in Border Collies with Imerslund-Gräsbeck syndrome (selective cobalamin malabsorption). PLoS One. 2013 Apr 16;8(4):e61144. doi: 10.1371/journal.pone.0061144. Print 2013.
Bo privasidat, bo eskoho
Nos ta usa kuki esensial pa manehá e wèpsait. Kuki opshonal (manera dunadónan di kontenido inkorporá) ta desabilitá pa default i ta wòrdu aktivá solamente si bo ta di akuerdo. Bo por kambia bo eskoho na kualke momento usando e boton “Cookies”.
Ta nesesario pa karakterístikanan prinsipal i seguridat. Semper aktivá.
Ta mehorá funshonnan manera sparmentu di preferensia òf inkorporashon no-propaganda.
Yuda nos komprondé e uso di e wèpsait. Deshabilitá pa default.
Propaganda/tracking atraves di wèpsaitnan (algun video/mapa ta inkorporá). Deshabilitá pa default.